Frizzled-related proteins contain a cysteine-rich domain (CRD) that is homologous to the Wnt-binding domain of Frizzled receptors . This domain enables FRPs to bind to Wnt ligands or Frizzled receptors, thereby modulating Wnt signaling . The human recombinant version of these proteins is produced using recombinant DNA technology, which involves inserting the gene encoding the protein into a suitable expression system, such as bacteria or mammalian cells, to produce the protein in large quantities .
The Wnt signaling pathway can be divided into two main branches: the canonical (β-catenin-dependent) pathway and the non-canonical (β-catenin-independent) pathway . FRPs can act as antagonists of the Wnt signaling pathway by binding to Wnt ligands and preventing them from interacting with Frizzled receptors . This inhibition can affect various cellular processes, including cell proliferation, differentiation, and migration .
Recombinant human FRPs are valuable tools in research and medicine due to their ability to modulate Wnt signaling . They are used in various applications, including:
In conclusion, Frizzled-related proteins are essential regulators of the Wnt signaling pathway, with significant implications for developmental biology, cancer research, and regenerative medicine. The recombinant production of these proteins has enabled their widespread use in various research and therapeutic applications.